Overview
Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%
Status:
Completed
Completed
Trial end date:
2008-02-01
2008-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To assess the potential of tretnoin gel 0.05% to produce phototoxic reactions, measured as skin reactions 24 and 48 hours after UV radiation of drug on skin.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Coria Laboratories, Ltd.Treatments:
Tretinoin
Criteria
Inclusion Criteria:- Normal healthy volunteers
- 18 years of age or older
Exclusion Criteria:
- Less than 18 years of age